Julia Kleinschmidt Senior Associate
Qualification
Lawyer, Maître en droit
Areas of expertise
Special sector knowledge
- Healthcare & life sciences
Languages
- German
- English
- French
Brief biography
- Since 2020 Forvis Mazars (formerly Mazars)
- 2018 – 2020 Associate at Dierks+Company Rechtanwaltsgesellschaft mbH (Berlin), Associate
- Traineeship at the Kammergericht (Court of Appeal) Berlin
- Law Student at the Humboldt University of Berlin and Université Panthéon-Assas in Paris (Maître en droit)
Profil
Julia Kleinschmidt has been a lawyer and Senior Associate at Forvis Mazars (formerly Mazars) since 2020. She is part of the healthcare praxis group, specializing in medical devices and digital health. She advises manufacturers of medical devices and service providers in the healthcare sector, such as universities, hospitals and physicians. Her primary focus is on the consultancy of manufacturers of medical devices, in vitro diagnostics and other healthcare providers regarding their Market Access. She is specialized in cost reimbursement law, physicians’ professional law and healthcare compliance. Previously to her employment at Forvis Mazars (formerly Mazars), she worked at two law firms in Berlin, specializing in Health Care and Life Sciences subjects.
Speaker activity
- Speaker for the startup qualification program "4C Accelerator Tübingen" (Funding partner: Ministry of Economics, Labor and Tourism Baden-Württemberg and its Startup BW campaign, B. Braun Foundation and Hector Foundation) since 2021
Want to know more?
Pages associated to Julia Kleinschmidt
Who we are
- Ambient Assisted Living
- Aktuelle regulatorische Erkenntnisse nach dem Geltungsbeginn der MDR
- Webinar: Digitalisierung im Gesundheitswesen – Compliance im Gesundheitswesen
- Webinar: Digitalisierung im Gesundheitswesen – Anforderungen an die Erstattungsfähigkeit von Digitalen Pflegeanwendungen (DiPA)
- Side event of the DMEA: “Go to market – legal and commercial aspects for digital health products in Germany”
- Sars-CoV-2-Antigenschnelltests wegen mangelnder Sensitivität in der Kritik
- Digitale Gesundheitsanwendungen
- Die DiPA steht in den Startlöchern – ein Überblick zum aktuellen Stand: „Leitfaden 0.9“
- Reimbursement von digitalen Medizinprodukten
- Referentenentwurf zum Digital-Gesetz (DigiG): DiGA – quo vadis?
- Zustand und Rahmenbedingungen des deutschen Pflegemarktes: Chancen für die Digitalisierung?